Bioasis Technologies Current Assets

Bioasis Technologies posts a current assets of $380K as of November 2022. That compares with $2.8M in the prior-year period — down 86.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bioasis Technologies's current assets was $2.8M. The latest reading is $380K — a 86.5% year-over-year decrease (period ending November 2022). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Bioasis Technologies's financial statement story. At $380K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BIOAF's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Bioasis Technologies's other metric pages and overview cover the third.

Judging Bioasis Technologies against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $380K here, then scan peer and history charts to see if the gap is persistent.